cancer clinical trials for Thoracic (ONC)

18 Thoracic (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  Current Status: Open

  View links and contact information related to this clinical trial

• Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO

  Current Status: Open

  View links and contact information related to this clinical trial

• Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153

  Current Status: Open

  View links and contact information related to this clinical trial

• Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I Study of IM-1021 in Participants with Advanced Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I/II Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized, Open-label Study of Serplulimab Plus Chemotherapy (Carboplatin-Etoposide) in Comparison With Atezolizumab Plus Chemotherapy in Previously Untreated US Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)

  Current Status: Open

  View links and contact information related to this clinical trial

• ESTABLISHMENT OF A NATIONAL BIOREPOSITORY TO ADVANCE STUDIES OF IMMUNE-RELATED ADVERSE EVENTS

  Current Status: Open

  View links and contact information related to this clinical trial

• Evaluation of Trabedersen (OT-101) with Pembrolizumab in Patients with Newly Diagnosed Advanced Non-Small Cell Lung Cancer and positive PD-L1

  Current Status: Open

  View links and contact information related to this clinical trial

• Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors

  Current Status: Not Open

  View links and contact information related to this clinical trial

• An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation

  Current Status: Open

  View links and contact information related to this clinical trial